Search research articles
Contact Us
Filters
Showing results (101-110 of 464) with videos related to
Page
of 47
Sort By:
Molecular Cancer
|
June 17, 2017
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
Basel Abu-Jamous, Francesca M Buffa, Adrian L Harris, et al.
Endocrine Reviews
|
October 23, 2003
Angiogenesis in endocrine tumors
Helen E Turner, Adrian L Harris, Shlomo Melmed, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
November 27, 2009
Targeting vascular endothelial growth factor in renal cell carcinoma
Nilay S Patel, Asif Muneer, Christopher Blick, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 21, 2006
Hypoxia-induced genetic instability--a calculated mechanism underlying tumor progression
L Eric Huang, Ranjit S Bindra, Peter M Glazer, et al.
The Lancet. Oncology
|
September 7, 2016
Imaging oligometastatic cancer before local treatment
James M Franklin, Ricky A Sharma, Adrian L Harris, et al.
British Journal of Cancer
|
August 10, 2023
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
Nicole D Machado, Lisa C Heather, Adrian L Harris, et al.
Cancer Research
|
March 3, 2006
Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1
Helen J Knowles, David R Mole, Peter J Ratcliffe, et al.
Genes & Development
|
March 11, 2017
A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1
Erkin Erdal, Syed Haider, Jan Rehwinkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis
Emma Hormbrey, Cheng Han, Anthony Roberts, et al.
Circulation Research
|
June 12, 2004
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases
Helen J Knowles, Ya-Min Tian, David R Mole, et al.
Page
of 47
Search research articles
Search
Showing results (101-110 of 464) with videos related to
Sort By:
Page
of 47
Molecular Cancer
|
June 17, 2017
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
Basel Abu-Jamous, Francesca M Buffa, Adrian L Harris, et al.
Endocrine Reviews
|
October 23, 2003
Angiogenesis in endocrine tumors
Helen E Turner, Adrian L Harris, Shlomo Melmed, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
November 27, 2009
Targeting vascular endothelial growth factor in renal cell carcinoma
Nilay S Patel, Asif Muneer, Christopher Blick, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
December 21, 2006
Hypoxia-induced genetic instability--a calculated mechanism underlying tumor progression
L Eric Huang, Ranjit S Bindra, Peter M Glazer, et al.
The Lancet. Oncology
|
September 7, 2016
Imaging oligometastatic cancer before local treatment
James M Franklin, Ricky A Sharma, Adrian L Harris, et al.
British Journal of Cancer
|
August 10, 2023
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
Nicole D Machado, Lisa C Heather, Adrian L Harris, et al.
Cancer Research
|
March 3, 2006
Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1
Helen J Knowles, David R Mole, Peter J Ratcliffe, et al.
Genes & Development
|
March 11, 2017
A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1
Erkin Erdal, Syed Haider, Jan Rehwinkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis
Emma Hormbrey, Cheng Han, Anthony Roberts, et al.
Circulation Research
|
June 12, 2004
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases
Helen J Knowles, Ya-Min Tian, David R Mole, et al.
Page
of 47